Fuyumi Kato

Publications

Citations

H-Index

2016

Active since

Affiliations

Institute of Predictive and Personalized Medicine of Cancer(Current)

Fuyumi Kato is an author at Institute of Predictive and Personalized Medicine of Cancer specializing in lung cancer, cancer research, and tumor biology.

Top concepts

MedicineImmunologyLung CancerCell BiologyTumor BiologyCancer BiologyCancer GeneticsCancer ResearchCell DevelopmentMolecular Medicine

Publications per year

2016–2016

Publications

<i>MYCL</i> is a target of a BET bromodomain inhibitor, JQ1, on growth suppression efficacy in small cell lung cancer cells

Fuyumi Kato, Francesco Paolo Fiorentino, Andreu Alibés et al. · Oncotarget · 2016 · 54 citations · Full text

Immunology, Cancer Biology, Tumor Biology +19

Rows per page

1–1 of 1